A single centre open-label non-inferiority trial to assess the immunogenicity and safety of an intradermal and an intramuscular single-visit dosing regimen of purified chick-embryo cell-culture rabies vaccine in adults.

The project HFM/21-13 - SINGLE-R is financed under the DFR call.